N/A N=42 Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
Type 2 Diabetes · Oxidative Stress
Primary: Concentration of Vitamin C in Type 2 Diabetic Patients. — 1.1; 1.2 umol/g tissue
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=20 A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
Diabetes Mellitus, Type 2
Primary: Maximum Absolute Value of Gallbladder Ejection Fraction (Emax GEF) During Cholecystokinin (CCK) Infusion, as a Measure of Maximum Effect — 47.4352; 38.4331 Percent of…
Phase 4 N=36 Effect of Weight and/or Obesity on Dapsone Drug Concentrations
Obesity · Leprosy · Tuberculosis
Primary: Serum Clearance — 2.55 L/h
Phase 4 N=71 A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
Macular Edema · Retinal Vein Occlusion
Primary: Change From Baseline in Best Corrected Visual Acuity (BCVA) at Month 6 — 51.90; 18.60 letters
Phase 3 N=209 A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology (ACR)20 Response at Week 24 — 24.6; 69.8; 24.6; 73.4 Percentage of Participants — p=<0.0001
N/A N=54 A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis
Onychomycosis
Primary: Percent (%) of Toenails Attaining 3 Millimeters (mm) or More of Clear Nail Growth — 67 Percent of Toenails
Phase 4 N=52 Efficacy of Patient Controlled Epidural Anesthesia Versus Continuous Epidural Analgesia for Post-thoracotomy Pain
Acute Post-thoracotomy Pain
Primary: Local Anesthetic Consumption — 1505.39; 1862.16 ug
N/A N=27 Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Metabolic Syndrome X · Prediabetic State
Primary: Insulin Sensitivity — 1.48; 1.73; 1.89; 2.93 mg*kg^-1*min^-1
N/A N=37 Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia
Rheumatoid Arthritis
Primary: Percentage of Participants on Tocilizumab Treatment at Month 6 After Treatment Initiation — 79.3; 100; 80; 84.4 percentage of participants
Phase 4 N=58 Drug and Talk Therapy for Fibromyalgia
Fibromyalgia
Primary: Change in Weekly Average Pain Intensity — -2.1; -0.97; -1.67 units on a scale
N/A N=221 Engaging Homeless Veterans in Primary Care
Homeless Persons
Primary: Receipt of Primary Care at the VA — 50; 39 participants
Phase 4 N=27 Post Hematopoietic Stem Cell Transplantation
Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
Primary: Number of Participants With Adverse Events, Serious Adverse Events and Deaths as a Measure of Safety and Tolerability — 25; 3; 0 Participants
Phase 2 N=36 Breast Cancer Risk Biomarkers in Premenopausal Women
Breast Cancer
Primary: The Proportion of Subjects That Complete an Intervention of Lovaza™ 4 Grams Per Day — 0.94 proportion of enrolled participants
N/A N=69 Lamotrigine Therapy in Geriatric Bipolar Depression
Bipolar Depression
Primary: Mean Glutamine to Creatine Ratio by Diagnosis at Baseline — .34; .36 mean serum Glutamine to Creatine ratio
Phase 4 N=78 Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
Osteoarthritis · Rheumatoid Arthritis · Lower Back Pain
Primary: Change in Box Scale-11 (BS-11) Pain Score — 6.2; 4.0 units on a scale